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Abstract
Introduction:  Following spinal cord injury, prostate undergoes atrophy probably due to
interruption of neuro-hormonal pathways. The incidence of carcinoma of prostate is lower in
patients with spinal cord injury above T-10 than in those with lesion below T-10.
Case presentation: A Caucasian male sustained T-4 paraplegia in 1991 at the age of 59-years. He
had long-term indwelling urethral catheter. In May 1995, routine blood test showed prostate-
specific antigen to be 17.7 mg/ml. Prostate biopsy revealed moderately differentiated primary
adenocarcinoma of prostate; Gleason score was 3+3. Bone scans showed no evidence of metastatic
bone disease. Bilateral orchidectomy was performed in September 1995. MRI of pelvis revealed no
evidence of spread beyond prostatic capsule. There was no pelvic lymphadenopathy. In October
1996, this patient got chest infection and recovered fully after taking amoxicillin. In February 2001,
he developed pneumonia and was prescribed cefuroxime intravenously. In March 2001, cystoscopy
and electrohydraulic lithotripsy of vesical calculi were carried out. In August 2001, this patient was
admitted to spinal unit for management of pressure sores. He expired on 28 June 2002 in local
hospital. Cause of death was recorded as acute ventricular failure, congestive heart failure, chronic
respiratory failure and spinal cord injury.
Conclusion: Although prostate gland undergoes atrophy in men who sustained spinal cord injury
in early age, physicians should be vigilant and look for prostatic diseases particularly in men, who
have sustained spinal cord injury during later period of life. Patients with cervical and upper dorsal
lesions are at risk of developing potentially life-threatening chest complications after major surgical
procedures including radical prostatectomy. Therefore, it may be advisable to consider
chemoprevention of prostate cancer with Finasteride, especially in men, who sustained cervical and
upper dorsal spinal cord injury during later part of their life.
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Introduction
Frisbie and associates from Spinal Cord Injury Service,
Department of Veterans Affairs Medical Centre, West
Roxbury, Massachusetts, USA, performed transrectal ultra-
sonic examination of prostate in spinal cord injury
patients. These patients were stratified by severity of paral-
ysis. Ultrasound scan revealed that the prostate gland of
severely paralysed spinal cord injury patients was small
[1]. Hvarness and associates from Department of Urology,
Rigshospitalet at the Copenhagen University in Denmark
found that men with spinal cord injury had a smaller
prostate than those men without spinal cord injury [2].
Atrophy of prostate following spinal cord injury is proba-
bly due to interruption of neuro-hormonal pathways due
to extensive cord damage.
Bartoletti and associates from University of Florence, Flor-
ence, Italy studied 113 spinal cord injury patients (mean
age 61.3) and 109 age-matched able-bodied subjects
(mean age 65.4); patients with spinal cord injury were
stratified according to age at onset of spinal cord injury.
Prostate-specific antigen value and prostate size were sig-
nificantly lower in patients with spinal cord injury than
those observed in able bodied subjects, and an inverse
relationship was observed in spinal cord injury patients
between these two parameters and patient age at the time
of spinal cord injury. No spinal cord injury patient pre-
sented with prostate cancer, while 9.7% of control sub-
jects were affected by prostate cancer [3]. Frisbie observed
that the incidence of carcinoma of prostate was lower in
myelopathy patients with higher levels of paralysis (T10
or above) than in those with lesions at T11 or below [4,5].
We report a Caucasian male with T-4 paraplegia in whom
high level of prostate-specific antigen was discovered dur-
ing routine blood test. Rectal examination revealed
enlarged prostate, which was not clinically malignant. But
histology of prostate biopsy showed adenocarcinoma.
This case illustrates the need to be vigilant not to miss car-
cinoma of prostate in spinal cord injury patients.
Case presentation
A 59-year-old, British Caucasian male was working in
security and was coming off duty at 0100 hours on 01
March 1991. Five lads tried to ambush the patient and
deliberately caused a head-on collision. This patient was
wearing a seat belt. He sustained fracture of mandible, left
3 - 8 ribs, left scapula, left humerus, left radius and ulna,
right 3 - 6 ribs, right femur, right distal fibula. He devel-
oped left haemothorax; chest tube drained 1300 ml of
blood. He was ventilated with endotracheal tube. Internal
fixation was performed of left humerus, left radius and
ulna. External fixation was applied to right femoral shaft.
After recovery, he was found to have paraplegia with sen-
sory level at T-4. X-rays of spine and myelogram revealed
no abnormality. It was presumed that paraplegia was due
to hypotension. Tracheostomy was performed on 19
March 1991. He was weaned off ventilator on 22 April
1991. He developed pressure sore in sacrum. He was man-
aging neuropathic bladder by indwelling urethral cathe-
ter.
On 10 May 1995, during a routine visit to spinal unit,
blood sample was sent for Prostate-specific antigen (PSA).
Prostate-specific antigen was 17.7 mg/ml. Examination
under anaesthesia revealed large, firm prostate but not
clinically malignant. Biopsies were taken on 12 Septem-
ber 1995. All cores of prostatic tissue were infiltrated by a
moderately differentiated primary adenocarcinoma of
prostate Gleason score 3+3. (Figures 1 and 2) Focal
perineural invasion was present. Bone scan was done on
18 September 1995, which showed no evidence of meta-
static bone disease. Bilateral orchidectomy was performed
on 19 September 1995. Microscopy revealed normal tes-
tes. MRI of pelvis, carried out on 23 October 1995,
revealed no evidence of any spread of prostatic malig-
nancy beyond the prostatic capsule. (Figures 3, 4 and 5)
The prostate measured 3 cm in diameter and appeared
well defined from rectum, levator ani muscles and semi-
nal vesicle. There was no pelvic lymphadenopathy.
In February 1996, this patient sustained injury to right
ankle while he was hoisted. X-ray showed fracture of distal
tibia and fibula. In October 1996, he developed chest
infection and was prescribed amoxicillin. In February
2001, this patient developed pneumonia. He received
Core biopsy of prostate (Haematoxylin and Eosin stain) is  extensively infiltrated by adenocarcinoma Figure 1
Core biopsy of prostate (Haematoxylin and Eosin 
stain) is extensively infiltrated by adenocarcinoma. 
The majority of the tumour is composed of poorly formed 
glands (Gleason pattern 4), contrasting with occasional 
larger, well-formed, benign glands at bottom.Cases Journal 2009, 2:9374 http://www.casesjournal.com/content/2/1/9374
Page 3 of 5
(page number not for citation purposes)
cefuroxime intravenously. He was experiencing repeated
catheter blocks. Flexible cystoscopy showed several calculi
in urinary bladder. In March 2001, cystoscopy and elec-
trohydraulic lithotripsy of vesical calculi were carried out.
Prostate-specific antigen levels during this patient's fol-
low-up are given in Table 1. In August 2001, this patient
was admitted to spinal unit for management of pressure
sores. He expired on 28 June 2002 in local hospital. Cause
of death was recorded as acute ventricular failure, conges-
tive heart failure, chronic respiratory failure and spinal
cord injury.
Discussion
In an elderly veteran population, digital rectal examina-
tion was found to result in a statistically significant but
clinically insignificant increase in serum PSA level [6].
Ornstein and associates from Division of Urologic Sur-
gery, Washington University School of Medicine, St. Louis
Missouri, USA observed that biological variation for total
and free prostate-specific antigen was 14.7 and 14.0%,
respectively. At 1 hour after rectal examination total and
free prostate-specific antigen increased by more than the
biological variation in 31 and 48 per cent of the men,
respectively [7]. Increases were significantly greater in
men whose initial prostate-specific antigen concentra-
tions were less than 4.0 ng/mL. There was a dramatic
Core biopsy of prostate (Haematoxylin and Eosin stain)  shows small areas of the tumour consist of discrete, rela- tively well-formed glands with open lumina (Gleason pattern  3) Figure 2
Core biopsy of prostate (Haematoxylin and Eosin 
stain) shows small areas of the tumour consist of dis-
crete, relatively well-formed glands with open lumina 
(Gleason pattern 3).
Magnetic Resonance Imaging of pelvis performed on 23  October 1995: Coronal T-2 weighted image shows no extra- capsular spread of carcinoma of prostate Figure 3
Magnetic Resonance Imaging of pelvis performed on 
23 October 1995: Coronal T-2 weighted image shows 
no extra-capsular spread of carcinoma of prostate. 
Seminal vesicles appear normal.
Magnetic Resonance Imaging of pelvis performed on 23  October 1995: Sagittal T-2 weighted image shows urinary  catheter in urethra Figure 4
Magnetic Resonance Imaging of pelvis performed on 
23 October 1995: Sagittal T-2 weighted image shows 
urinary catheter in urethra. There is no extra-capsular 
spread of carcinoma of prostate.
Magnetic Resonance Imaging of pelvis performed on 23  October 1995: Axial T-2 weighted image shows no extra- capsular spread of carcinoma of prostate Figure 5
Magnetic Resonance Imaging of pelvis performed on 
23 October 1995: Axial T-2 weighted image shows no 
extra-capsular spread of carcinoma of prostate.Cases Journal 2009, 2:9374 http://www.casesjournal.com/content/2/1/9374
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increase in total and percentage of free prostate-specific
antigen in all men 1 hour after prostatic biopsy. Total
prostate-specific antigen remained elevated for at least 1
week in most men, while percentage of free prostate-spe-
cific antigen returned to within or less than the biological
variation of the baseline level in 90% of the men by 24
hours.
Some spinal cord injury patients undergo manual evacua-
tion of bowels or digital check of rectum to avoid bowel
accidents; these procedures can lead to transient elevation
of prostate-specific antigen level in blood. Therefore, a
time gap of 48 hours should be allowed before prostate-
specific antigen is checked in these patients. Otherwise,
men with tetraplegia and paraplegia, in whom manual
evacuation of bowels is performed, or digital check of rec-
tum is carried out twice or three times a day may be sub-
jected to unnecessary prostate biopsies just because
prostate-specific antigen level was above the upper limit
of laboratory reference range.
Patients with cervical or upper dorsal spinal cord injury
have limited cardio-respiratory reserve. Therefore, these
patients are at high risk for developing serious pulmonary
complications after major surgery such as radical prostate-
ctomy. Our patient was not considered for radical prosta-
tectomy for the same reason. Tetraplegic subjects and
those with upper dorsal lesions are at risk of developing
potentially life-threatening complications after major sur-
gical procedures including radical prostatectomy. There-
fore, it may be advisable to consider chemoprevention for
prostate cancer, especially in men, who sustained cervical
and upper dorsal spinal cord injury during later part of
their life. Recently, the Prostate Cancer Prevention Trial
enrolled 18 882 men aged > or = 55 years with a prostate-
specific antigen level of < 3.0 ng/mL and normal digital
rectal examination findings, and randomized them to Fin-
asteride 5 mg daily or placebo [8]. Prostate cancer data
from evaluable biopsies obtained within 7 years plus < or
= 90 days of randomization were examined. Finasteride
significantly reduced the risk of prostate cancer relative to
placebo across multiple Gleason scores (4 through 7),
including a 58% reduction in Gleason score 5 prostate
cancer risk (P < .0001), a 52% reduction in Gleason score
6 prostate cancer risk (P < .0001), and a 22% reduction in
Gleason score 7 prostate cancer risk (P = .0368). Re-eval-
uation of the results based on the pathology of the radical
prostatectomy specimens and longer follow-up showed a
30% reduction in cancer incidence with Finasteride and
no significant differences in Gleason scores compared
with placebo [9]. Modelling studies suggest that with Fin-
asteride, the risk of high-grade cancer is unchanged or
reduced. Sexual dysfunction and gynecomastia were
observed but the rates were low [10].
Conclusion
Although prostate gland undergoes atrophy in men who
sustained spinal cord injury in early age, physicians
should be vigilant not to miss carcinoma of prostate par-
ticularly in men, who have sustained spinal cord injury
during later period of life. Some spinal cord injury
patients undergo manual evacuation of bowels or digital
check of rectum to avoid bowel accidents; these proce-
dures can lead to transient increase in prostate-specific
antigen level in blood. This should be borne in mind oth-
erwise, some of these patients, who undergo manual evac-
uation of bowels, or digital check of rectum twice or three
times a day may be subjected to unnecessary prostate
biopsies just because prostate-specific antigen level is
above the upper limit of laboratory reference range. Tetra-
plegic subjects and those with upper dorsal lesions are at
risk of developing potentially life-threatening complica-
tions after major surgical procedures including radical
prostatectomy. Therefore, it may be advisable to consider
chemoprevention of prostate cancer with Finasteride,
especially in men, who sustained cervical and upper dor-
sal spinal cord injury in later part of their life.
Consent
Unfortunately, this patient had left us for heavenly abode
several years ago. The spinal unit lost touch with the
patient's family as well. Therefore, it is not possible to
obtain written informed consent from the patient or
patient's next of kin for publication of this case report and
accompanying images. We do not think that neither the
patient nor his relatives would have objected to presenta-
tion of this case in Cases Journal, as primary purpose of
publication is education of health professionals leading to
improved quality of care of spinal cord injury patients.
Table 1: Prostate-specific antigen levels during follow-up after 
this patient underwent bilateral orchidectomy on 19 September 
1995.
Date Prostate-specific antigen (ng/mL)
10 May 1995 17.7
11 September 1995 21.8
23 October 1995 1.9
16 January 1996 2.5
07 February 1996 2.7
25 March 1996 1.8
19 June 1996 1.9
11 September 1996 2.2
23 October 1996 2.3
15 January 1997 1.7
15 April 1997 1.6
15 July 1997 1.3
21 October 1997 1.0
20 January 1998 1.4
20 April 1998 1.7
06 February 2001 2.4
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